PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions-Reference-Cited by-同舟云学术

PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions

Published:2020-05-09 Issue:10 Volume:146 Page:2607-2620
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Toda Yu,Kohashi Kenichi,Yamada Yuichi,Yoshimoto Masato,Ishihara Shin,Ito Yoshihiro,Iwasaki Takeshi,Yamamoto Hidetaka,Matsumoto Yoshihiro,Nakashima Yasuharu,Mawatari Masaaki,Oda Yoshinao^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-020-03242-6.pdf

Reference52 articles.

1. Abiko K, Mandai M, Hamanishi J et al (2013) PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction. Clin Cancer Res 19:1363–1374. https://doi.org/10.1158/1078-0432.CCR-12-2199

2. Abiko K, Matsumura N, Hamanishi J et al (2015) IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. Br J Cancer 112:1501–1509. https://doi.org/10.1038/bjc.2015.101

3. Angela Y, Haferkamp S, Weishaupt C et al (2019) Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases. Cancer Immunol Immunother 68:1187–1194. https://doi.org/10.1007/s00262-019-02353-5

4. Dunn GP, Koebel CM, Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006:836–848

5. Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ (2018) Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol 9:847. https://doi.org/10.3389/fimmu.2018.00847

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRG4 represses the genesis and metastasis of osteosarcoma by inhibiting PDL1 expression;Tissue and Cell;2024-06

2. Cancer mRNA vaccines: clinical advances and future opportunities;Nature Reviews Clinical Oncology;2024-05-17

3. Lipid Peroxidation-Related Redox Signaling in Osteosarcoma;International Journal of Molecular Sciences;2024-04-22

4. Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8+ T cell infiltration;British Journal of Cancer;2024-01-30

5. Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer;Neoplasia;2023-10